Exosomica

The goal of biotechnology startup Exosomica, is to develop and commercialise advanced therapies against Parkinson’s disease. Exosomica was founded in 2019 by Dr. Augustas Pivoriūnas, the leading stem cell researcher in Lithuania and the science management, consulting and investment company. Exosomica has received a nearly 1 Mio EUR investment throu EU funds for a research project. During the project, Exosomica aims to develop the technology for the production and therapeutic use of small-scale laboratory exosomes. We believe that our the new technology will help for millions people who are suffering from Parkinson`s decease.